2 domains / 4 areas / 2 specializations
Mclean Hospital
Data updated
Harvard Medical School-affiliated psychiatric hospital and one of the leading mental health research institutions in the United States. Operates a dedicated Ketamine Service for treatment-resistant depression and is actively expanding into psilocybin research for depression, bipolar disorder, and other psychiatric conditions.
Academic Research
0 papersPublished Papers
0
Trial Involvement
4
Distinct Focus Topics
0
Latest Publication
Unknown
Clinical Care Delivery Snapshot
Health Systems & HospitalsProvider Model
Health System / Hospital Program
Organization Status
Unknown
Psychedelic Services
Ketamine + Esketamine Services
Service Coverage
Global
Service Profile
Care Settings
Service Modalities
Payer Models
Non-Psychedelic Service Mix
Unknown
Care Delivery Notes
Backfilled profile for existing L2 clinical care delivery stakeholder.
Quick Facts
- Type
- Other
- HQ
- United States
- Website
- Visit